ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
280.56
-1.02
( -0.36% )
Updated: 21:13:00

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
280.56
Bid
280.53
Ask
280.57
Volume
104,793
279.43 Day's Range 282.035
0.11 52 Week Range 380.01
Market Cap
Previous Close
281.58
Open
280.56
Last Trade
1
@
280.56
Last Trade Time
21:13:00
Financial Volume
-
VWAP
-
Average Volume (3m)
573,860
Shares Outstanding
483,252,729
Dividend Yield
0.55%
PE Ratio
51.53
Earnings Per Share (EPS)
5.47
Revenue
14.69B
Net Profit
2.64B

About CSL Limited

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Melbourne, Victoria, Aus
Founded
1916
CSL Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker CSL. The last closing price for CSL was AUD281.58. Over the last year, CSL shares have traded in a share price range of AUD 0.11 to AUD 380.01.

CSL currently has 483,252,729 shares outstanding. The market capitalization of CSL is AUD136.07 billion. CSL has a price to earnings ratio (PE ratio) of 51.53.

CSL Latest News

Travere Therapeutics Shares Touch 52-Week Low on FSGS Study Data

By Colin Kellaher Shares of Travere Therapeutics tumbled nearly 35% and hit a new 52-week low Tuesday after the biopharmaceutical company said a pivotal Phase 3 study of its kidney drug Filspari...

Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration

By Chris Wack Arcturus Therapeutics Holdings Inc. shares were up 31% to $24.03 after it entered into a strategic collaboration with CSL Seqirus for the research, development, manufacture and...

Arcturus Up 26% After Hours on CSL Seqirus Vaccine Collaboration

By Josh Beckerman Arcturus Therapeutics Holdings Inc. shares rose 26% to $23.10 after hours as the company announced a vaccine collaboration with CSL Ltd.'s CSL Seqirus. Arcturus will receive...

Publication of definitive Interim Result for Vifor Pharma tender offer: CSL Behring AG declares offer successful

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220307005938/en/ AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL...

Vifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Billion

By Joshua Kirby Shares in Vifor Pharma AG rose sharply in opening trade Tuesday after receiving an offer from Australia's CSL Ltd. that values the company at $11.7 billion. At 0812 GMT...

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd Update

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it has made a US$11.7 billion all-cash offer for Switzerland's Vifor Pharma Ltd. as it aims to add renal-disease...

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- Update

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. has made an all-cash offer for Vifor Pharma Ltd. that values the Swiss pharmaceutical developer's equity at US$11.7...

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it had made an all-cash offer for Vifor Pharma Ltd. that values the Swiss pharmaceutical developer's equity at...

CSL in Talks With Vifor Pharma Over Potential Transaction

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it is in talks with Vifor Pharma Ltd. over a potential acquisition of the Switzerland-based pharmaceutical company. CSL...

Covid-19 Vaccine Candidate Scrapped After False Positives on HIV Tests

By Mike Cherney SYDNEY -- A Covid-19 vaccine candidate in Australia has been scrapped because recipients returned false positives on certain HIV tests, underscoring the difficulties scientists...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.09-1.08937070333283.65288.01279.43264124282.36692028DE
4-0.44-0.156583629893281360.01160.01538588279.64542835DE
12-13.91-4.72374095833294.47360.01160.01573860284.09556097DE
26-12.61-4.30125865539293.17360.01160598270293.87463941DE
52-5.45-1.90552777875286.01380.010.11641198289.10208141DE
156-8-2.77238702523288.56380.010.11729706279.79070917DE
2605.762.096069869274.84000.11785846285.18790216DE

CSL - Frequently Asked Questions (FAQ)

What is the current CSL share price?
The current share price of CSL is AUD 280.56
How many CSL shares are in issue?
CSL has 483,252,729 shares in issue
What is the market cap of CSL?
The market capitalisation of CSL is AUD 136.07B
What is the 1 year trading range for CSL share price?
CSL has traded in the range of AUD 0.11 to AUD 380.01 during the past year
What is the PE ratio of CSL?
The price to earnings ratio of CSL is 51.53
What is the cash to sales ratio of CSL?
The cash to sales ratio of CSL is 9.27
What is the reporting currency for CSL?
CSL reports financial results in USD
What is the latest annual turnover for CSL?
The latest annual turnover of CSL is USD 14.69B
What is the latest annual profit for CSL?
The latest annual profit of CSL is USD 2.64B
What is the registered address of CSL?
The registered address for CSL is 45 POPLAR ROAD, PARKVILLE, MELBOURNE, VICTORIA, 3052
What is the CSL website address?
The website address for CSL is www.csl.com.au
Which industry sector does CSL operate in?
CSL operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ARVOCArtemis Resources Limited
AUD 0.002
(100.00%)
500k
LYNLycaon Resources Ltd
AUD 0.145
(61.11%)
2.86M
MRDMount Ridley Mines Ltd
AUD 0.004
(33.33%)
217.37k
AAUAntilles Gold Limited
AUD 0.004
(33.33%)
4.27M
AOAAusmon Resources Limited
AUD 0.002
(33.33%)
3.4M
LU7OLithium Universe Ltd
AUD 0.001
(-66.67%)
3.5M
ADXOADX Energy Limited
AUD 0.006
(-45.45%)
153.13k
T88Taiton Resources Ltd
AUD 0.09
(-33.33%)
2.36k
MTLMantle Minerals Limited
AUD 0.001
(-33.33%)
15.53k
PKOPeako Limited
AUD 0.002
(-33.33%)
2.59M
AMDArrow Minerals Limited
AUD 0.002
(0.00%)
90.03M
GCMGreen Critical Minerals Ltd
AUD 0.017
(21.43%)
79.42M
BRNBrainchip Holdings Ltd
AUD 0.445
(14.10%)
46.49M
TMGTrigg Minerals Ltd
AUD 0.044
(15.79%)
27.47M
ATHAlterity Therapeutics Ltd
AUD 0.008
(0.00%)
27.12M

Discussion

View Full Feed
gitreal gitreal 5 minutes ago
No relevance to AABB. Nobody is shorting this garbage, which currently trades below 2 cents.

But pull that tin foil hat tighter, and watch out for those black helicopters circling your house.
AABB
Lime Time Lime Time 6 minutes ago
Trump's win was a landslide given what he was up against. The U.S. media.

America voted in a proven leader and winner. A fighter that will never give up.

Women are very rare to be leaders. Kamala was not a leader. It's very rare to see a woman be a leader. The majority
luckydude777 luckydude777 8 minutes ago
Wishing all who read this board a happy new year in your pursuit of making profits in the Tripple Q's.

Long or short the 3xQ's ... there's always profit to be made.

No offerings - no surprise R/S's - no toxic debt conversions - no dilution-pollution. No slippery deal
TQQQ
glenn1919 glenn1919 9 minutes ago
PET.....CYCC.....ARBB.....https://stockcharts.com/h-sc/ui?s=PET&p=W&yr=1&mn=3&dy=0&id=p96837884856
ARBB CYCC
kthomp19 kthomp19 10 minutes ago
What happens to the current commons if FNMA/FMCC are set free and an IPO happens?

There are many things that can happen. The most important is whether the senior prefs are exchanged for common shares, like with AIG, or written off.

Other important considerations include
AIG FMCC
Jetmek_03052 Jetmek_03052 10 minutes ago
None of your post has ANYTHING to DO with DBMM's failure to attract clients and FINALLY get their "business" untracked.

EVERYONE can see what you are doing. But go right ahead....keep BS'ing.

It's the ONLY thing you do. And EVERYONE knows it.
DBMM
kthomp19 kthomp19 10 minutes ago
As I've explained previously, it doesn't matter for my purposes.

So you expect me to answer questions, with specifics, that you refuse to answer yourself. Forget 5 in a row, you're going for a full blackout on the hypocrisy bingo card.

The only "probabilities" I worry a
FNMA
kthomp19 kthomp19 10 minutes ago
I think this is the fundamental difference in theories. It's going to be exceedingly difficult to raise large amounts of capital if new investors are getting such a small piece of the pie. And it makes a huge difference between 80% and 95%. At only 5% shareholder owned, how much equity can they poss
FNMA
kthomp19 kthomp19 10 minutes ago
My zeal for picking apart posts is directly proportional to the amount of smugness and narcissism of the post.

Bullshit. You let https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175577792 posts like this one slide without replying all the time.

You tel
FNMA
kthomp19 kthomp19 10 minutes ago
You want to silence people who have valid points, just because they aren't taking legal action.

They don't have to shut up per se, they just have to accept the consequences of being shown to be hypocrites by constantly claiming things are illegal with no plans to do anything about it.
FNMA
kthomp19 kthomp19 10 minutes ago
Wow, Ackman going to knock down the Three Fifty Wall.

Looks like even he bounced off of it.

I have a different hypothesis: there is a Three Fifty Magnet, as in the FNMAS:FNMA ratio tends to come back to 3.50:1. It has been like that for the last 7 years.

FNMAS
kthomp19 kthomp19 11 minutes ago
Maybe Bill Ackman just wants to get rid of some of his many Fannie shares at the end of the year, now that he is finally back in the black. To do so, he needs hype, otherwise massive selling could depress the stock price.

I doubt it. I don't think Ackman is the kind to do a short-term
FNMA
kthomp19 kthomp19 11 minutes ago
I still go with $47. Who are you going to believe - an actual $15 Target calculator with actual numbers or Ackman?

Ackman updated his estimate to $31. Why would you still use $47?

Again - all about the Seniors. And your risk return preference re juniors v. common.
FNMA
kthomp19 kthomp19 11 minutes ago
Warrants being taken will only prolong this and further delay a return to full private mode as an emergency motion will be filed as a taking by a smart well financed group.

Good luck with that. The NWS was ruled to not be a taking by dint of the CAFC dismissing the cases and the Supre
FNMA
kthomp19 kthomp19 11 minutes ago
Some may say a closure to that case, will open the door for more lawsuits.. but i doubt anymore lawsuits is going to happen..

This after https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175599609 you already threatened a lawsuit of your own ?

If Treasury
FNMA
kthomp19 kthomp19 11 minutes ago
FNMA will increase to $8 from now to year end.

Come again?

Price in 2016 year end after Trump win was $4. Markets doubled in the past 8 years. Price in 2024 year end after Trump win will be $8.

Classic case of "garbage in, garbage out".
FNMA
kthomp19 kthomp19 11 minutes ago
Will zoom past 4 today but settle at 3.9s or 3.8s for EOy 2024

4 what? CAD?
FNMA
kthomp19 kthomp19 11 minutes ago
He held 100 million shares long before Mnuchin was Treasury secretary.

He also bought 11M shares of FNMAS equivalent while Mnuchin was Treasury Secretary, partly because "it hedges our risk of a
restructuring that disproportionately benefits the preferred versus the common shar
DJT FNMAS
kthomp19 kthomp19 11 minutes ago
I thought he had preferred as a hedge.

He does. https://assets.pershingsquareholdings.com/2024/08/15133212/Pershing-Square-Holdings-Ltd.-June-2024-Interim-1.pdf Pershing Square's mid-year 2024 report shows $55.353M worth of Preferred Stock on page 28, which is the rough equivalent
FNMAS
kthomp19 kthomp19 12 minutes ago
I think this is how Ackman may have arrived at his price target.

No, that can't be right. Writing off the seniors would write the $72,468 line to zero and add that same amount to Retained Earnings, bringing it to positive $46,156.

Ackman's analysis includes the assumpt
FNMA
devil dog 96 devil dog 96 12 minutes ago
I still can't believe they just reduced their already micro O/S by another 6.5 million shares. 🔥

ATMH already had one of the smallest share structures in the OTC but now it's even smaller. 🏆️


https://investorshub.advfn.com/uimage/uploads/2024/12
ATMH
tedpeele tedpeele 14 minutes ago
Nonsense. Anyone even halfway paying attention knows each and every one of those statements are indisputable.
LWLG
Investor082 Investor082 17 minutes ago
The dude has been gaslighting and changing his narrative for the last 10 odd years. Worldwide approvals and reimbursements, Project Orbis, and the list goes on, LOL!
NWBO
glenn1919 glenn1919 17 minutes ago
cycc...........................https://stockcharts.com/h-sc/ui?&s=cycc&id=p80904663129&listNum=4&a=1431976465
CYCC

Your Recent History

Delayed Upgrade Clock